C3.ai, Inc. (AI) Spending and interest coverage
- R&D / revenue · 12 months: Value 90.79%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 111.10%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 90.79% | Research and development expense / revenue. Period ending 2026-07-31. $210.99M ÷ $232.38M × 100 ≈ 90.79% |
| Stock-based compensation / revenue · 12 months | 111.10% | Share-based compensation / revenue. Period ending 2026-07-31. $258.17M ÷ $232.38M × 100 ≈ 111.10% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 210.99M USD | Research and Development Expense |
| Revenue | 232.38M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 258.17M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -471.95M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $210.99M | $232.38M | $258.17M | $-471.95M | (m) | 90.79% | 111.10% | (m) | (m) |
| 2026-04-30 | $229.09M | $250.27M | $263.71M | $-498.50M | (m) | 91.54% | 105.37% | (m) | (m) |
| 2026-01-31 | $240.22M | $307.39M | $266.14M | $-466.31M | (m) | 78.15% | 86.58% | (m) | (m) |
| 2025-10-31 | $240.75M | $352.91M | $252.90M | $-413.48M | (m) | 68.22% | 71.66% | (m) | (m) |
| 2025-07-31 | $238.12M | $372.10M | $241.08M | $-376.66M | (m) | 63.99% | 64.79% | (m) | (m) |
| 2025-04-30 | $226.39M | $389.06M | $230.99M | $-324.42M | (m) | 58.19% | 59.37% | (m) | (m) |
| 2025-01-31 | $218.62M | $366.92M | $231.10M | $-317.77M | (m) | 59.58% | 62.98% | (m) | (m) |
| 2024-10-31 | $208.74M | $346.54M | $223.43M | $-312.73M | (m) | 60.24% | 64.48% | (m) | (m) |
| 2024-07-31 | $203.42M | $325.43M | $219.56M | $-316.83M | (m) | 62.51% | 67.47% | (m) | (m) |
| 2024-04-30 | $201.37M | $310.58M | $215.76M | $-318.34M | (m) | 64.83% | 69.47% | (m) | (m) |
| 2024-01-31 | $200.43M | $296.40M | $207.10M | $-309.31M | (m) | 67.62% | 69.87% | (m) | (m) |
| 2023-10-31 | $206.00M | $284.67M | $207.95M | $-298.81M | (m) | 72.36% | 73.05% | (m) | (m) |
| 2023-07-31 | $205.65M | $273.85M | $210.79M | $-291.38M | (m) | 75.10% | 76.97% | (m) | (m) |
| 2023-04-30 | $210.66M | $266.80M | $216.54M | $-290.49M | (m) | 78.96% | 81.16% | (m) | (m) |
| 2023-01-31 | $207.36M | $266.70M | $204.10M | $-273.74M | (m) | 77.75% | 76.53% | (m) | (m) |
| 2022-10-31 | $193.24M | $269.81M | $179.63M | $-249.10M | (m) | 71.62% | 66.58% | (m) | (m) |
| 2022-07-31 | $179.71M | $265.66M | $156.16M | $-232.81M | (m) | 67.65% | 58.78% | (m) | (m) |
| 2022-04-30 | $150.54M | $252.76M | $113.44M | $-196.12M | (m) | 59.56% | 44.88% | (m) | (m) |
| 2022-01-31 | $124.88M | $232.73M | $85.28M | $-163.51M | (m) | 53.66% | 36.65% | (m) | (m) |
| 2021-10-31 | $102.69M | $212.06M | $60.51M | $-134.60M | (m) | 48.43% | 28.53% | (m) | (m) |
| 2021-07-31 | $82.30M | $195.14M | $33.17M | $-93.45M | (m) | 42.18% | 17.00% | (m) | (m) |
| 2021-04-30 | $68.86M | $183.22M | $21.74M | $-60.26M | (m) | 37.58% | 11.87% | (m) | (m) |
| 2021-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | $64.55M | $156.67M | $8.31M | $-71.50M | (m) | 41.20% | 5.30% | (m) | (m) |
| 2020-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-04-30 | $37.32M | $91.61M | $4.27M | $-36.04M | (m) | 40.74% | 4.66% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.